Acknowledging the importance of machinery design in advancing industrial progress and performance, the A' Manufacturing and ...

Eli Lilly and insitro said the deals offers a “new paradigm” for collaborations between major pharmaceutical companies and ...

As the pharmaceutical sector endeavours to become more sustainable, we hear how digital twins – virtual replicas of systems ...

This high-quality ready-to-use (RTU) solution is designed to meet the rigorous standards and increasing requirements of the ...

AI-based clinical simulation systems can be a game-changer for the pharmaceutical industry. The ability to predict clinical ...

GEA, one of the world's largest suppliers of systems and components for the food, beverage and pharmaceutical industries, has ...

The latest deal in AI drug discovery is a twist on the usual big pharma-startup collaboration model, with Insitro licensing technology and Lilly eligible for royalties.

Kvantify has launched a new computational method that can accelerate the early phases of drug discovery. The method stands ...

Lancaster, California Thursday, October 10, 2024, 11:00 Hrs [IST] ...

In January last year, German biotech company BioNTech acquired African AI startup InstaDeep for over $550 million, a deal ...

The global drug designing tools market is on the brink of an unprecedented surge, set to experience substantial growth at a steady Compound Annual Growth Rate (CAGR) of 8.7% from 2023 to 2033.

To get the most from generative AI, businesses must transform their workplace culture ...